Page 2 - Dave Santos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rigel Pharmaceuticals Acquires U S Rights to GAVRETO®

/PRNewswire/ Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has entered into a definitive agreement to acquire the U.S. rights.

United statesSouth san franciscoDavid rosenDave santosRaul rodriguezRoche groupDrug administrationExchange commissionBlueprint medicines corporationRigel pharmaceuticals incAmerican cancer societyRigel pharmaceuticalsLung diseaseLysis syndromeImpaired wound healingFetal toxicity

Rigel Pharma (RIGL) Acquires U S Rights to GAVRETO from Blueprint Medicines (BPMC)

Rigel Pharma (RIGL) Acquires U S Rights to GAVRETO from Blueprint Medicines (BPMC)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Raul rodriguezDave santosRigel pharmaceuticals incBlueprint medicines corporationRoche groupDrug administrationRigel pharmaceuticalsLung diseaseLysis syndromeImpaired wound healingFetal toxicity

After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel

After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesRoche genentechEli lillyRigel rezlidhiaDave santosRigel pharmaceuticalsMerck coBlueprint medicinesBig pharmaGreat chinaRoyalty pharmaForma therapeutics

Rigel Pharmaceuticals: Push To Profitability Continues, But COVID Beacon Extinguished

Rigel Pharmaceuticals: Push To Profitability Continues, But COVID Beacon Extinguished
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesEli lillyDave santosNational heart lungUs department of defenseAmerican society of hematologyBlood instituteNational heartMidcap financialPublic health emergencyDepartment of defenseNational institutes of healthRigel pharmaceuticals incRigel pharmaceuticalsHealth emergencyEmergency use authorization

Rigel Pharmaceuticals, Inc (NASDAQ:RIGL) Q3 2023 Earnings Call Transcript

Operator: Greetings, and welcome to Rigel Pharmaceuticals Financial Conference Call for the Third Quarter of 2023. At this time, all participants are in listen-only mode.

United statesSan diegoRay fureyRaul rodriguezKristen kluskaDave santosEli lillyRick millerEun yangAmerican cancer societyRigel pharmaceuticals incCantor fitzgeraldOnline jewelry stores in the worldRigel pharmaceuticalsCall transcript novemberRigel pharmaceuticals financial conference call